Ortikos
- Product NDC
- 55566-1020
- 11-digit product format
- 555661020
- Labeler code
- 55566
- Product ID
- 55566-1020_69c1e200-f5ae-429f-b890-b2418700a7e8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Budesonide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Ferring Pharmaceuticals Inc.
- Application
- NDA211929
- Marketing category
- NDA
- Marketing start
- 2020-07-20
- Marketing end
- 0000-00-00
- Substance
- BUDESONIDE
- Active strength
- 9 mg/1
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55566-1020-1 | 55566102001 | 30 CAPSULE in 1 BOTTLE (55566-1020-1) | 30 capsule | 2020-07-20 | 0000-00-00 | No | No | Current |